Issue 23, 2019

An ROS-responsive and self-accelerating drug release nanoplatform for overcoming multidrug resistance

Abstract

An ‘on-demand’ drug release and ROS-responsive nanoparticle was prepared by chemically conjugating hydrophobic α-tocopheryl succinate to hydrophilic poly(ethylene glycol) via a thioketal linker. This nanoparticle encapsulated with doxorubicin and α-tocopheryl succinate exhibited remarkable efficiency in reversing multidrug resistance both in vitro and in vivo.

Graphical abstract: An ROS-responsive and self-accelerating drug release nanoplatform for overcoming multidrug resistance

Supplementary files

Article information

Article type
Communication
Submitted
15 Jan 2019
Accepted
20 Feb 2019
First published
20 Feb 2019

Chem. Commun., 2019,55, 3383-3386

An ROS-responsive and self-accelerating drug release nanoplatform for overcoming multidrug resistance

X. Lv, Y. Zhu, H. Ghandehari, A. Yu and Y. Wang, Chem. Commun., 2019, 55, 3383 DOI: 10.1039/C9CC00358D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements